European equities traded in the US as American depositary receipts started the week sharply higher late Monday morning, rising 1.21% to 1,812.72 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and software firm SAP (SAP), which rose 2.4% and 2.1%, respectively. They were followed by lender Banco Santander (SAN) and telecommunications company Ericsson (ERIC), which were up 2% and 1.8%, respectively.

The decliners from continental Europe were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which fell 6.4% and 3.1%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.8% and 0.9%, respectively.

From the UK and Ireland, the gainers were led by mining company BHP Group (BHP) and utilities company National Grid (NGG), which advanced 2.1% and 1.8%, respectively. They were followed by pharmaceutical company GSK (GSK) and lender Lloyds Banking Group (LYG), which increased 1.7% each.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which dropped 6.6% and 6.1%, respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which lost 4.8% and 4%, respectively.